Busey Bank’s Acadia Pharmaceuticals ACAD Stock Holding History

Busey Bank’s Portfolio ACAD Stock Details ACAD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-12,391	Closed	-$191K	–	342
2024 Q3	$191K	Hold	12,391	–	–	0.01%	337
2024 Q2	$201K	Hold	12,391	–	–	0.01%	332
2024 Q1	$229K	Hold	12,391	–	–	0.01%	325
2023 Q4	$388K	Hold	12,391	–	–	0.01%	258
2023 Q3	$258K	Sell	12,391 -438	-3%	-$11.9K	0.01%	273
2023 Q2	$307K	Hold	12,829	–	–	0.01%	270
2023 Q1	$241K	Hold	12,829	–	–	0.01%	293
2022 Q4	$204K	Sell	12,829 -171	-1%	-$2.67K	0.01%	310
2022 Q3	$213K	Hold	13,000	–	–	0.01%	296
2022 Q2	$183K	Hold	13,000	–	–	0.01%	312
2022 Q1	$315K	Buy	+13,000	New	+$315K	0.01%	286

Other funds holding ACAD

BBA

Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $724M AUM 96.91% 1-Year Est. Return

Busey Bank's ACAD Position: Q4 2024 in Review

Busey Bank sold out of Acadia Pharmaceuticals (ACAD) in Q4 2024, closing a stake of 12,391 shares — an estimated $191K sold.

Busey Bank first reported a position in ACAD in Q1 2022 and held it in 11 quarters. The position peaked at $388K in Q4 2023. 296 funds tracked by Wall St. Rank hold ACAD as of Q4 2024.

Busey Bank reported no remaining Acadia Pharmaceuticals position as of Q4 2024 after selling out during the quarter.
Busey Bank sold 12,391 Acadia Pharmaceuticals shares in Q4 2024, an estimated $191K.
Busey Bank first reported a position in Acadia Pharmaceuticals in Q1 2022 and held it in 11 quarters.
Busey Bank's Acadia Pharmaceuticals position peaked at $388K in Q4 2023.
296 funds tracked by Wall St. Rank held Acadia Pharmaceuticals as of Q4 2024.

Based on Busey Bank's 13F filing for Q4 2024, filed 23 Jan 2025.